You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GH Sale Disclosure
Freeman Chris · SEC Form 4 · Filed Aug 11, 2026
Sale
Calculated transaction value
$1.24M
Freeman Chris Chief Commercial Officer
GH
Transaction date
Aug 10, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 1 day later
GH daily price context
Close on/before transaction
$167.21
Aug 10, 2026
First close after public filing
$165.11
Aug 12, 2026
30-day return after filing
-3.68%
Through Sep 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,365 shares @ $168.79
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001871615-26-000016
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$15.5M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Guardant Health, Inc. GH | Sale | Aug 10, 2026 | $2.96M |
| Guardant Health, Inc. GH | Sale | Aug 10, 2026 | $6M |
| Guardant Health, Inc. GH | Exercise | Aug 10, 2026 | $0 |
| Guardant Health, Inc. GH | Sale | Aug 10, 2026 | $579.64K |
| Guardant Health, Inc. GH Current | Sale | Aug 10, 2026 | $1.24M |
| Guardant Health, Inc. GH | Exercise | Aug 10, 2026 | $3.91M |
| Guardant Health, Inc. GH | Exercise | Aug 10, 2026 | $0 |
| Guardant Health, Inc. GH | Exercise | Aug 10, 2026 | $799.84K |